Corvus Pharmaceuticals Inc — Balance Sheet (NASDAQ:CRVS) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Total assets 85.53 M109.45 M68.24 M45.55 M68.91 M Total liabilities 13.38 M12.29 M12.13 M6.87 M36.34 M Total equity 72.15 M97.16 M56.12 M38.68 M32.57 M Total liabilities & shareholders' equities 85.53 M109.45 M68.24 M45.55 M68.91 M Total debt ————— Net debt —————

Haberler

Corvus Pharmaceuticals, Inc. (CRVS) Discusses Phase 1 Clinical Trial Results of Soquelitinib in Atopic Dermatitis with Focus on Cohort 4 - Slideshow (NASDAQ:CRVS) 2026-01-27

Corvus Pharmaceuticals Stock Rallies 209% in a Month: Here's Why

Corvus Pharmaceuticals (CRVS) Is Up 211.80% in One Week: What You Should Know

Wall Street Analysts Think Corvus (CRVS) Could Surge 25.29%: Read This Before Placing a Bet

Intel, Oracle among market cap stock movers on Monday

Revolution Medicines, Erasca And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Ambitions Enterprise Mgmt (NASDAQ:AHMA), Argo Blockchain (NASDAQ:ARBK)

Apple, Microsoft, Meta To Report Results; Fed’s Interest Rate Decision In Focus

Corvus Pharmaceuticals arrecada US$ 201,2 milhões em oferta pública ampliada

Corvus Pharmaceuticals raises $201.2 million in upsized public offering

Cantor Fitzgerald mantém classificação acima da média para ações da Corvus Pharmaceuticals

Cantor Fitzgerald reiterates Overweight rating on Corvus Pharmaceuticals stock

Jefferies eleva preço-alvo das ações da Corvus Pharmaceuticals para US$ 42 após dados positivos de Alzheimer